Processa Pharmaceuticals Statistics
Total Valuation
PCSA has a market cap or net worth of $5.73 million. The enterprise value is $5.53 million.
| Market Cap | 5.73M |
| Enterprise Value | 5.53M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PCSA has 2.79 million shares outstanding. The number of shares has increased by 652.98% in one year.
| Current Share Class | 2.79M |
| Shares Outstanding | 2.79M |
| Shares Change (YoY) | +652.98% |
| Shares Change (QoQ) | +4.86% |
| Owned by Insiders (%) | 3.71% |
| Owned by Institutions (%) | 23.88% |
| Float | 2.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87
| Current Ratio | 0.87 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -464.20% and return on invested capital (ROIC) is -276.38%.
| Return on Equity (ROE) | -464.20% |
| Return on Assets (ROA) | -156.79% |
| Return on Invested Capital (ROIC) | -276.38% |
| Return on Capital Employed (ROCE) | 4,051.82% |
| Weighted Average Cost of Capital (WACC) | 9.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.12M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.41% in the last 52 weeks. The beta is 0.97, so PCSA's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -56.41% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 42.80 |
| Average Volume (20 Days) | 41,214 |
Short Selling Information
The latest short interest is 67,319, so 2.41% of the outstanding shares have been sold short.
| Short Interest | 67,319 |
| Short Previous Month | 215,851 |
| Short % of Shares Out | 2.41% |
| Short % of Float | 2.67% |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.86M |
| Pretax Income | -13.44M |
| Net Income | -13.44M |
| EBITDA | -12.86M |
| EBIT | -12.86M |
| Earnings Per Share (EPS) | -$5.59 |
Balance Sheet
The company has $196,325 in cash and no debt, with a net cash position of $196,325 or $0.07 per share.
| Cash & Cash Equivalents | 196,325 |
| Total Debt | n/a |
| Net Cash | 196,325 |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | -317,341 |
| Book Value Per Share | -0.11 |
| Working Capital | -320,551 |
Cash Flow
| Operating Cash Flow | -11.97M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,204 |
| Net Borrowing | -3,752 |
| Free Cash Flow | -11.97M |
| FCF Per Share | -$4.29 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PCSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -652.98% |
| Shareholder Yield | -652.98% |
| Earnings Yield | -234.67% |
| FCF Yield | -209.06% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 17, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Dec 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |